PeaceHealth Behavioral Health Services will soon be partnering with researchers at the University of Oregon to help develop targeted treatments for high-risk adolescents and young adults with schizophrenia.
Part of a $52 million grant from the National Institutes of Health led by the Yale University Department of Psychiatry, the UO-PeaceHealth collaboration is one of 27 teams across the country and the only one from the Northwest in the new consortium, the Psychosis Risk Outcomes Network.
PeaceHealth’s primary role in the research will be identifying and recruiting patients and administering psychological, cognitive and medical assessments. The UO will try to understand how the brain changes for at-risk adolescents to better develop diagnostic and treatment strategies using magnetic resonance imaging at the UO’s Lewis Center for NeuroImaging and an electroencephalogram in the UO’s Department of Human Physiology.
